Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI
Clinical trial NCT07775391 · RECRUITING
Trial details
- NCT number
- NCT07775391
- Sponsor
- Shenzhen Wingor Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-03
- Primary completion
- 2028-09-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.